{"originalText": "，患者因罹患“结肠癌”于2013-08-06在我院予行全麻上姑息性右半结肠切除术，术后病理（9750.2013），：（横结肠）腺癌（中度分化），部分呈粘液腺癌图像，浸润溃疡型，面积7*6CM，侵穿浆膜，于肠壁脂肪组织内查见转移灶3处。呈肠壁一站（2/6个）、二站（1/1个）、“肠系膜根部”（1/1个）、“肠系膜中动脉根部”（2/2个）淋巴结癌转移。中间组（1个）淋巴结未查见癌。，术后病理分期：T4N2M0，IIIC期。术后已行6周期化疗，，化疗方案为：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时给予止吐、升血、增强免疫等治疗，因肿瘤指标仍有升高，依情于2014-03-31开始更改化疗方案，，具体用药为：伊利替康200MG D1、D8+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时辅以镇吐、升血、免疫调节等对症支持治疗。化疗期间耐受良好。自下次出院以来，患者一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。现患者为行复查并辅助化疗而再来我院就诊，门诊依情以“结肠术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠可；肛门排气排便好。近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 7, "end_pos": 10}, {"end_pos": 40, "label_type": "手术", "overlap": 0, "start_pos": 30}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 58, "end_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 102, "end_pos": 103}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 118, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 185}, {"end_pos": 232, "label_type": "药物", "overlap": 0, "start_pos": 228}, {"end_pos": 245, "label_type": "药物", "overlap": 0, "start_pos": 241}, {"end_pos": 259, "label_type": "药物", "overlap": 0, "start_pos": 256}, {"end_pos": 335, "label_type": "药物", "overlap": 0, "start_pos": 331}, {"end_pos": 351, "label_type": "药物", "overlap": 0, "start_pos": 347}, {"end_pos": 365, "label_type": "药物", "overlap": 0, "start_pos": 362}, {"end_pos": 461, "label_type": "解剖部位", "overlap": 0, "start_pos": 460}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 492, "end_pos": 496}, {"end_pos": 530, "label_type": "解剖部位", "overlap": 0, "start_pos": 528}]}
